US Patent Issued to ALLIFE MEDICINE (BEIJING) on April 14 for "Method for preparing hemogenic endothelium cell and method for preparing hematopoietic stem cell or hematopoietic stem and progenitor cell" (Chinese Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,954, issued on April 14, was assigned to ALLIFE MEDICINE (BEIJING) Ltd. (Beijing).

"Method for preparing hemogenic endothelium cell and method for preparing hematopoietic stem cell or hematopoietic stem and progenitor cell" was invented by Rulong Du (Beijing), Lei Yu (Beijing), Wenjing Huang (Beijing), Xuening Wu (Beijing), Yuchun Gu (Beijing) and Lida Wu (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for preparing hematopoietic endothelial cells and a method for preparing hematopoietic stem cells are provided, comprising inducing hematopoietic mesodermal cells to express transcription factors LCOR, HOXA9, HOXA5, RUNX1, and ERG at...